<?xml-stylesheet type='text/xsl' href='rsspretty.xsl' version='1.0'?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <atom:link href="http://www.law360.com/company_articles/1041" rel="self" type="application/rss+xml"/>
    <title>Law360: CVS</title>
    <link>http://www.law360.com/</link>
    <description>Latest articles for organization: CVS</description>
    <copyright>Copyright 2009 Portfolio Media, Inc.</copyright>
    <language>en-US</language>
    <image>
      <url>http://www.law360.com/images/headings/logo.gif</url>
      <title>Law360</title>
      <link>http://www.law360.com/</link>
    </image>
    <item>
      <title>BPA MDL Against Bottle Makers Survives Bid To Toss</title>
      <link>http://www.law360.com/articles/133506</link>
      <description>A federal judge allowed some claims to go forward Tuesday in multidistrict litigation that targets baby bottle and &#8220;sippy cup&#8221; makers over their use of bisphenol A, saying the companies cannot escape liability because the U.S. Food and Drug Administration has determined that the chemical may safely be used as a food additive.</description>
      <guid>http://www.law360.com/articles/133506</guid>
    </item>
    <item>
      <title>Asst. Managers Move For Cert. In CVS Overtime Action</title>
      <link>http://www.law360.com/articles/133073</link>
      <description>A group of assistant store managers suing CVS Caremark Corp. for allegedly failing to properly pay overtime has moved for collective action certification, and asked the court to order the drugstore chain to turn over its employment records so the plaintiffs can begin contacting potential class members.  </description>
      <guid>http://www.law360.com/articles/133073</guid>
    </item>
    <item>
      <title>Antitrust Concerns Revived As CVS Reveals FTC Probe</title>
      <link>http://www.law360.com/articles/132917</link>
      <description>The Federal Trade Commission has launched a probe of CVS Caremark Corp., raising questions about the focus of the investigation given recent complaints from lawmakers, unions and community drugstores that the 2007 merger of the drugstore giant with a pharmacy benefits manager has curbed competition. </description>
      <guid>http://www.law360.com/articles/132917</guid>
    </item>
    <item>
      <title>Target, CVS, Others Face Relacore Fraud Action</title>
      <link>http://www.law360.com/articles/131954</link>
      <description>Consumers have hit Target Corp., CVS Caremark Corp., Wal-Mart Stores Inc. and several others with a putative class action alleging that the companies made misleading claims about the effectiveness of weight-loss product Relacore or sold the product knowing it was "worthless."</description>
      <guid>http://www.law360.com/articles/131954</guid>
    </item>
    <item>
      <title>Plaintiffs Seek Cert. In Weight Loss Products Fraud Suit</title>
      <link>http://www.law360.com/articles/131711</link>
      <description>A group of consumers has asked a federal judge to certify three classes &#8212; each of which would purportedly consist of at least 10,000 people &#8212; in a lawsuit accusing Wal-Mart Stores Inc., Zoller Laboratories LLC and others of making fraudulent claims about weight loss products Zantrex-3 and Akavar 20/50.</description>
      <guid>http://www.law360.com/articles/131711</guid>
    </item>
    <item>
      <title>High Court Rebuffs Rx.com's Group Boycott Suit</title>
      <link>http://www.law360.com/articles/131839</link>
      <description>The U.S. Supreme Court has declined to hear Internet pharmacy Rx.com Inc.'s challenge to the dismissal of its case accusing pharmacy benefit managers Caremark Rx Inc., Medco Health Solutions Inc. and Express Scripts Inc. of violating the Sherman Act by instituting a group boycott.</description>
      <guid>http://www.law360.com/articles/131839</guid>
    </item>
    <item>
      <title>$110M E-Ferol Settlement Gets Tentative Court OK</title>
      <link>http://www.law360.com/articles/128284</link>
      <description>A federal judge has given the initial green light to O'Neal Inc., former Revco DS Inc. unit Retrac Inc. and several of their insurers for a settlement of up to $110 million in a class action over E-Ferol, a toxic vitamin solution manufactured by Retrac's predecessor and given to premature infants in the mid-1980s.</description>
      <guid>http://www.law360.com/articles/128284</guid>
    </item>
    <item>
      <title>Rite Aid Moves To Dismiss &#8216;Redundant&#8217; OT Suit</title>
      <link>http://www.law360.com/articles/127375</link>
      <description>Rite Aid Corp. has moved to dismiss a putative overtime class action filed by a former drugstore employee, saying it is identical to another class action filed earlier.</description>
      <guid>http://www.law360.com/articles/127375</guid>
    </item>
    <item>
      <title>Hayes Lemmerz Creditors Try To Shred Ch. 11 Plan</title>
      <link>http://www.law360.com/articles/126973</link>
      <description>Creditors have pelted Hayes Lemmerz International Inc. with objections to a broadly supported amended plan of reorganization they say is amiss, not least because the bankrupt wheel maker failed to obtain consent from certain lenders before arranging debtor-in-possession financing. </description>
      <guid>http://www.law360.com/articles/126973</guid>
    </item>
    <item>
      <title>ING Resolves TQP Data Encryption Patent Suit </title>
      <link>http://www.law360.com/articles/125913</link>
      <description>TQP Development LLC has dropped ING Groep NV from an ongoing patent infringement lawsuit accusing a slew of major companies &#8212; including Ticketmaster Entertainment Inc. MetLife Inc., Apple Inc. and eBay Inc. &#8212; of infringing its online encrypted data transmission method.</description>
      <guid>http://www.law360.com/articles/125913</guid>
    </item>
    <item>
      <title>Neurontin Plaintiffs Make Bid For Class Certification</title>
      <link>http://www.law360.com/articles/124772</link>
      <description>Plaintiffs are seeking to obtain class status in a multidistrict litigation accusing Pfizer Inc. and its Warner-Lambert Co. subsidiary of using patent litigation to postpone generic competition for epilepsy treatment Neurontin.</description>
      <guid>http://www.law360.com/articles/124772</guid>
    </item>
    <item>
      <title>CVS, Wal-Mart Seek Toss Of Drug Overcharge Action</title>
      <link>http://www.law360.com/articles/124806</link>
      <description>CVS Pharmacy Inc., Walgreen Co., Wal-Mart Stores Inc. and others have asked a judge to dismiss a proposed class action accusing them of overcharging for generic drugs by not passing along discounts to consumers.</description>
      <guid>http://www.law360.com/articles/124806</guid>
    </item>
    <item>
      <title>Deal Pros Brace For More Antitrust 2nd Looks</title>
      <link>http://www.law360.com/articles/123965</link>
      <description>Should the Federal Trade Commission take heed of pressure to begin a new review of the 2007 deal that created CVS Caremark Corp., it would be just the latest in an increasing number of deals to receive post-consummation review.</description>
      <guid>http://www.law360.com/articles/123965</guid>
    </item>
    <item>
      <title>Apple, Ticketmaster Latest Targets Of TQP Patent Suit</title>
      <link>http://www.law360.com/articles/122793</link>
      <description>Ticketmaster Entertainment Inc., Apple Inc. and Exxon Mobil Corp. are among a slew of major companies that have been sued by TQP Development LLC, alleging infringement of a patent related to an online encrypted data transmission method.</description>
      <guid>http://www.law360.com/articles/122793</guid>
    </item>
    <item>
      <title>Reps Join Push To Reopen CVS Caremark Probe</title>
      <link>http://www.law360.com/articles/122376</link>
      <description>Eight members of Congress &#8212; four Democrats and four Republicans &#8212; have asked the Federal Trade Commission in a letter to reopen its investigation into the 2007 merger that formed CVS Caremark Corp., citing concerns about competition and consumer privacy.</description>
      <guid>http://www.law360.com/articles/122376</guid>
    </item>
    <item>
      <title>Bronx Manager Hits Rite Aid With OT Class Action</title>
      <link>http://www.law360.com/articles/120479</link>
      <description>A Bronx, N.Y., former drugstore employee has filed a putative class action against Rite Aid Corp., claiming the national chain failed to pay her overtime.</description>
      <guid>http://www.law360.com/articles/120479</guid>
    </item>
    <item>
      <title>Walgreen Hits Cephalon Over Provigil Generic Deals </title>
      <link>http://www.law360.com/articles/119788</link>
      <description>Walgreen Co., Safeway Inc. and three others have become the latest retailers to accuse Cephalon Inc. of striking illegal deals with generic-drug makers to keep a copycat version of narcolepsy drug Provigil off the market. </description>
      <guid>http://www.law360.com/articles/119788</guid>
    </item>
    <item>
      <title>CVS, Others Hit With Suit Over Generics Prices</title>
      <link>http://www.law360.com/articles/119636</link>
      <description>Two Minnesota-based employee health funds have accused CVS Pharmacy Inc., Walgreen Co., Wal-Mart Stores Inc. and other pharmacies of overcharging customers for generic drugs, illegally hiking up prices instead of passing on the discounts they receive in the acquisition of generics to consumers.
</description>
      <guid>http://www.law360.com/articles/119636</guid>
    </item>
    <item>
      <title>Judge Keeps Neurontin Case Against Pfizer Intact</title>
      <link>http://www.law360.com/articles/119373</link>
      <description>A federal judge has cleared the way for the multidistrict litigation alleging Pfizer Inc. and its Warner-Lambert Co. subsidiary engaged in a scheme to use patent litigation to delay generic competition for the epilepsy drug Neurontin to move forward.</description>
      <guid>http://www.law360.com/articles/119373</guid>
    </item>
    <item>
      <title>CVS Settles With Last 2 Pharmacy Techs in FLSA Suit</title>
      <link>http://www.law360.com/articles/119439</link>
      <description>CVS Caremark Corp. has reached a confidential settlement with the two remaining plaintiffs in a wage-and-hour suit over the retailer's alleged failure to compensate pharmacy technicians for overtime, missed meal breaks, and duties performed before and after their scheduled shifts. </description>
      <guid>http://www.law360.com/articles/119439</guid>
    </item>
  </channel>
</rss>
